CH407128A - Process for the preparation of new iminodibenzyl derivatives - Google Patents
Process for the preparation of new iminodibenzyl derivativesInfo
- Publication number
- CH407128A CH407128A CH368962A CH368962A CH407128A CH 407128 A CH407128 A CH 407128A CH 368962 A CH368962 A CH 368962A CH 368962 A CH368962 A CH 368962A CH 407128 A CH407128 A CH 407128A
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- acid
- iminodibenzyl
- imino
- amine
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- ZSMRRZONCYIFNB-UHFFFAOYSA-N 6,11-dihydro-5h-benzo[b][1]benzazepine Chemical class C1CC2=CC=CC=C2NC2=CC=CC=C12 ZSMRRZONCYIFNB-UHFFFAOYSA-N 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title description 3
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 6
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 125000005041 acyloxyalkyl group Chemical group 0.000 claims description 2
- 125000003282 alkyl amino group Chemical group 0.000 claims description 2
- 125000005277 alkyl imino group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- -1 disubstituted sulfamoyl radical Chemical class 0.000 description 30
- 150000001875 compounds Chemical class 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000155 melt Substances 0.000 description 5
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001339 alkali metal compounds Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000004081 narcotic agent Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N p-toluenesulfonic acid Substances CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000005853 β-dimethylaminoethyl group Chemical group 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Verfahren zur Herstellung von neuen Iminodibenzylderivaten Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von neuen N-heterocyclischen. Ver bindungen mit wertvollen pharmakologischen Eigen schaften.
In einem Benzolring durch einen disubstituierten Sulfamoylrest substituierte Iminodibenzylderivate sind bisher nicht bekanntgeworden. Es wurde nun über raschenderweise gefunden, dass solche Verbindungen der Formel I
EMI0001.0008
in der R1 und R2 niedere Alkylreste, welche unter sich direkt oder über ein Sauerstoffatom verbunden sein können,
Z einen geradkettigen oder verzweigten Alkylenrest mit 2-6 Kohlenstoffatomen und Am eine niedere Alkylamino- oder Dialkylaminogruppe bedeuten, wobei beide Alkylreste einer Dialkylamino- gruppe Am unter sich direkt oder über ein Sauer stoffatom, eine Iminogruppe, eine niedere Alkyl- imino-,
Hydroxyalkylimino- oder Alkanoyloxyalkyl- iminogruppe verbunden. sein können, wertvolle pharmakologische Eigenschaften, insbesondere anti allergische, antiemetische und sedative Wirksamkeit besitzen, sowie auch die Wirkung anderer Arznei stoffe, insbesondere von Narkotica, potenzieren.
In den Verbindungen der Formel I sind R, und R2 beispielsweise durch Methyl-, Äthyl-, n-Propyl- oder n-Butylreste verkörpert oder bilden zusammen mit dem anliegenden Stickstoffatom z. B. den 1-Pyrrolidinyl , Piperidino- oder 4-Morpholinylrest.
Z ist beispielsweise ein Athylen-, Propylen-, Trimethylen-, 1-Methyl-trimethylen-, 2 Methyl-trimethylen-, 1,3 Dimethyl-trimethylen-, 2,2-Dimethyl-trimethylen-, Tetramethylen-, Pentamethylen- oder Hexamethylenrest, und Am z.
B. ein Methylamino-, Äthylamino-, n-Propylamino-, Isopropylamino-, n-Butylamino-, Dimethylamino-, Methyl-äthylamino-, Diäthylamino-, Methyl-n-propylamino-, Methyl-isopropylamino-, Di-n-butylamino-, Di-isobutylamino-, 1-Pyrrolidinyl-, Piperidino-, Hexamethylenimino-, 4 Morpholinyl-,
1-Piperazinyl , 4-Methyl 1 piperazinyl-, 4-Isopropyl-l-piperazinyl-, 4-(ss-Hydroxyäthyl)-1-piperazinyl-, 4-(ss Acetoxy-äthyl)-1-piperazinyl- oder 4 ;B Hydroxypropyl 1-piperazinylrest.
Die neuen Verbindungen der Formel I stellt man erfindungsgemäss her, indem man einen reaktions fähigen Ester einer Verbindung der Formel 1I,
EMI0001.0081
insbesondere ein Halogenid, wie beispielsweise ein Chlorid oder Bromid, oder ferner einen p-Toluol- sulfonsäureester, mit einem Amin der Formel III Am -H (11I) um. Die Umsetzung kann beispielsweise bei mässig hoher Temperatur von z.
B. 60-120 in einem inerten Lösungsmittel, wie z. B. einem niedermole kularen Alkanol oder Alkanon, erfolgen, wobei zweckmässig ein überschuss des umzusetzenden Amins als säurebindendes Mittel verwendet wird. Je nach dem Siedepunkt des verwendeten Amins, und des Lösungsmittels sowie der benötigten Reaktions temperatur ist die Umsetzung gegebenenfalls im ge schlossenen Gefäss durchzuführen.
Zu reaktionsfähigen Estern von Verbindungen der Formel 1I gelangt man beispielsweise durch Um setzung von Alkalimetallderivaten von geeigneten 3-Sulfamoyl-iminodibenzylen, deren Sulfamoylrest disubstituiert ist, mit Alkylenoxyden und Umsetzung der erhaltenen Hydroxyalkylderivate mit anorgani schen Säurehalogeniden, Mothansulfonsäurechlorid oder Arylsulfonsäurechloriden,
wobei in der Sulf- amoylgruppe disubstituierte 5-Halogenalkyl-, 5-Methansulfonyloxyalkyl- bzw. 5 Arylsulfonyloxyalkyl-3-sulfamoyl-imino- dibenzyle erhalten werden.
Zu solchen Verbindungen kann man aber auch in einer Stufe durch Umsetzung von Alkalimetallverbindungen von 3-Dialkylsulfamoyl- iminodibenzylen mit nichtgeminalen Dihalogenalka- nen, insbesondere solchen mit zwei verschiedenen Halogenatomen, oder mit Arylsulfonsäurehalogen- alkylestern gelangen.
Die reaktionsfähigen Ester von Verbindungen der Formel II können beispielsweise mit Dimethylamin, Methyläthylamin, Diäthylamin, Di-n-butylamin, Methylamin, Äthylamin, n-Propylamin, n-Butylamin, Pyrrolidin, Piperidin, Hexamothylenimin, Morpholin, 4-Methyl-piperazin, 4-(ss-Hydroxyäthyl)
-piperazin oder 4-(ss-Acetoxy-äthyl)-piperazin umgesetzt werden.
Mit anorganischen oder organischen Säuren, wie beispielsweise Salzsäure, Bromwasserstoffsäure, Schwefelsäure, Phosphorsäure,, Methansulfonsäure, Äthandisulfonsäure, ss-Hydroxyäthansulfonsäure, Essigsäure, Bernsteinsäure, Fumarsäure, Maleinsäure, Äpfelsäure, Weinsäure, Citronensäure, Benzoesäure, Sahcylsäure und Mandelsäure bilden die;
tertiären Basen Salze, welche zum Teil wasserlöslich sind.
In den nachfolgenden Beispielen bedeuten Teile Gewichtsteile; diese verhalten sich zu Volumteilen wie g zu cm3. Die Temperaturen sind in Celsius graden angegeben.
<I>Beispiel 1</I> 40 Teile 3-Dimethylsulfamoyl-5-(3'-chlor-propyl)- iminodibenzyl werden mit 30 Volumteilen Dimethyl- amin und 50 Volumteilen Methanol während 12 Stunden im Autoklaven auf 110 erhitzt. Das Re aktionsgemisch wird vom überschüssigen Dimethyl- amin und vom Methanol befreit und in Äther auf genommen. Die Ätherlösung wird mit Wasser ge waschen und darauf mit 2n Salzsäure ausgezogen.
Der salzsaure Extrakt wird mit konz. Natronlauge alkalisch gestellt und die ausgeschiedene Base aber mals mit Äther extrahiert. Der Extrakt wird mit Wasser und über Natriumsulfat getrocknet. Nach dem Abdestillieren des Lösungsmittels hintorbleiben 34 Teile rohes Reaktionsprodukt, aus dem das 3-Dimethylsulfamoyl-5-(y-dimethylamin-propyl)- iminodibenzyl als Hydrochlorid vom Smp. l89 isoliert wird.
In analoger Weise entsteht bei der Reaktion von Dimethylsulfamoyl-5-(3'-chlor-propyl)- iminodibenzyl mit Methylamin das 3-Dimethylsulfamoyl-5-(3'-methylamino- propyl)-iminodibenzyl, dessen Hydrochlorid bei 133 schmilzt.
<I>Beispiel 2</I> 25 Teile 3-Dimethylsulfamoyl - 5 - (2'-methyl-3'- chlor-propyl)-iminodibenzyl werden in 200 Volum- teilen Butanon gelöst und mit 16 Teilen N-(2-Hy- droxy-äthyl)-piperazin und 15 Teilen Natriumjodid unter energischem Rühren während 18 Stunden ge kocht. Darauf wird das Lösungsmittel unter redu ziertem Druck abdestilliert und der Rückstand in Chloroform aufgenommen.
Nach analoger Aufarbei tung wie in Beispiel 1 erhält man das 3-Dimethylsulfamoyl-5-[2'-methyl-3'-(4" hydroxyäthyl-1"-piperazinyl)-propyl]- iminodibenzyl.
Das Oxalat der Base schmilzt unter Zersetzung bei 158 .
In einer analogen Weise, wie dies in den vor stehenden Beispielen beschrieben ist, können auch die folgenden Verbindungen hergestellt werden: 3-Dimethylsulfamoyl-5-(ss-dimethylamino-äthyl)- iminodibenzyl-Hydrochlorid, Smp. 210 ; 3-Dimethylsulfamoyl-5-(y-dimethylamino- f-methyl-propyl)-iminodibenzyl vom Smp. 1l1 ; 3-Dimethylsulfamoyl-5-(y-dimethylamino- n-butyl)-iminodibenzyl vom Smp. 90 ;
3-Dimethylsulfamoyl-5-[y-(4'-methyl-piperazinyl)- ss-methyl-propyl]-iminodibenzyl, dessen Oxalat bei 193 schmilzt; 3-Dimethy@sulfamoyl-5-(y-methylamino-f- methyl-propyl)-iminodibenzyl, dessen Oxalat bei 216 schmilzt; 3-Dimethylsulfamoyl-5-[y-(1'-piperazinyl)- ss-methyl-propyl]-iminodibenzyl, dessen Oxalat bei 168 schmilzt.
Process for the preparation of new iminodibenzyl derivatives The present invention relates to a process for the preparation of new N-heterocyclic ones. Compounds with valuable pharmacological properties.
Iminodibenzyl derivatives substituted in a benzene ring by a disubstituted sulfamoyl radical have not yet become known. It has now been found, surprisingly, that such compounds of the formula I
EMI0001.0008
in which R1 and R2 are lower alkyl radicals, which can be linked directly or via an oxygen atom,
Z is a straight-chain or branched alkylene radical with 2-6 carbon atoms and Am is a lower alkylamino or dialkylamino group, both alkyl radicals of a dialkylamino group Am, directly or via an oxygen atom, an imino group, a lower alkyl imino,
Hydroxyalkylimino or alkanoyloxyalkyl imino group connected. can be, have valuable pharmacological properties, in particular anti-allergic, anti-emetic and sedative effectiveness, as well as the effect of other drugs, especially narcotics, potentiate.
In the compounds of the formula I, R and R2 are embodied, for example, by methyl, ethyl, n-propyl or n-butyl radicals or, together with the adjacent nitrogen atom, form e.g. B. the 1-pyrrolidinyl, piperidino or 4-morpholinyl radical.
Z is, for example, an ethylene, propylene, trimethylene, 1-methyl-trimethylene, 2-methyl-trimethylene, 1,3-dimethyl-trimethylene, 2,2-dimethyl-trimethylene, tetramethylene, pentamethylene or hexamethylene radical , and On z.
B. a methylamino, ethylamino, n-propylamino, isopropylamino, n-butylamino, dimethylamino, methyl-ethylamino, diethylamino, methyl-n-propylamino, methyl-isopropylamino, di-n-butylamino -, di-isobutylamino, 1-pyrrolidinyl, piperidino, hexamethyleneimino, 4 morpholinyl,
1-piperazinyl, 4-methyl, 1-piperazinyl-, 4-isopropyl-1-piperazinyl-, 4- (ss-hydroxyethyl) -1-piperazinyl-, 4- (ss-acetoxyethyl) -1-piperazinyl- or 4; B. Hydroxypropyl 1-piperazinyl radical.
The new compounds of the formula I are prepared according to the invention by adding a reactive ester of a compound of the formula 1I,
EMI0001.0081
in particular a halide, such as, for example, a chloride or bromide, or also a p-toluenesulfonic acid ester, with an amine of the formula III Am —H (11I). The reaction can, for example, at a moderately high temperature of, for.
B. 60-120 in an inert solvent, such as. B. a low molecular alkanol or alkanone, it is useful to use an excess of the amine to be reacted as an acid-binding agent. Depending on the boiling point of the amine used and the solvent and the required reaction temperature, the reaction may have to be carried out in a closed vessel.
Reactive esters of compounds of the formula 1I are obtained, for example, by reacting alkali metal derivatives of suitable 3-sulfamoyl-iminodibenzylene, the sulfamoyl radical of which is disubstituted, with alkylene oxides and reacting the hydroxyalkyl derivatives obtained with inorganic acid halides, mothanesulfonic acid chloride or aryl sulfonic acid chlorides,
5-haloalkyl-, 5-methanesulfonyloxyalkyl- or 5-arylsulfonyloxyalkyl-3-sulfamoyl-imino-dibenzyls disubstituted in the sulfamoyl group are obtained.
Such compounds can, however, also be obtained in one step by reacting alkali metal compounds of 3-dialkylsulfamoyl-iminodibenzylene with nongeminal dihaloalkanes, in particular those having two different halogen atoms, or with arylsulphonic acid haloalkyl esters.
The reactive esters of compounds of the formula II can, for example, with dimethylamine, methylethylamine, diethylamine, di-n-butylamine, methylamine, ethylamine, n-propylamine, n-butylamine, pyrrolidine, piperidine, hexamothylenimine, morpholine, 4-methyl-piperazine, 4 - (ss-hydroxyethyl)
-piperazine or 4- (ss-acetoxy-ethyl) -piperazine are implemented.
With inorganic or organic acids, such as hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, methanesulfonic acid, ethanesulfonic acid, β-hydroxyethanesulfonic acid, acetic acid, succinic acid, fumaric acid, maleic acid, malic acid, tartaric acid, citric acid, benzoic acid, saccylic acid and mandelic acid;
tertiary base salts, some of which are water-soluble.
In the following examples, parts mean parts by weight; these are related to parts of volume as g to cm3. The temperatures are given in degrees Celsius.
<I> Example 1 </I> 40 parts of 3-dimethylsulfamoyl-5- (3'-chloro-propyl) - iminodibenzyl are heated to 110 for 12 hours in an autoclave with 30 parts by volume of dimethylamine and 50 parts by volume of methanol. The reaction mixture is freed from excess dimethylamine and methanol and taken up in ether. The ether solution is washed with water and then extracted with 2N hydrochloric acid.
The hydrochloric acid extract is mixed with conc. Sodium hydroxide solution made alkaline and the precipitated base was extracted with ether. The extract is dried with water and over sodium sulfate. After the solvent has been distilled off, 34 parts of crude reaction product remain, from which 3-dimethylsulfamoyl-5- (γ-dimethylaminopropyl) iminodibenzyl is isolated as the hydrochloride with a melting point of 189.
In an analogous manner, the reaction of dimethylsulfamoyl-5- (3'-chloropropyl) - iminodibenzyl with methylamine gives 3-dimethylsulfamoyl-5- (3'-methylaminopropyl) -iminodibenzyl, the hydrochloride of which melts at 133.
<I> Example 2 </I> 25 parts of 3-dimethylsulfamoyl - 5 - (2'-methyl-3'-chloro-propyl) -iminodibenzyl are dissolved in 200 parts by volume of butanone and mixed with 16 parts of N- (2-Hy - Droxy-ethyl) piperazine and 15 parts of sodium iodide boiled with vigorous stirring for 18 hours. The solvent is then distilled off under reduced pressure and the residue is taken up in chloroform.
After working up analogously as in Example 1, 3-dimethylsulfamoyl-5- [2'-methyl-3 '- (4 "hydroxyethyl-1" -piperazinyl) propyl] - iminodibenzyl is obtained.
The oxalate of the base melts at 158 with decomposition.
In a manner analogous to that described in the above examples, the following compounds can also be prepared: 3-dimethylsulfamoyl-5- (ss-dimethylamino-ethyl) - iminodibenzyl hydrochloride, m.p. 210; 3-dimethylsulfamoyl-5- (γ-dimethylamino-f-methyl-propyl) -iminodibenzyl of melting point 11; 3-dimethylsulfamoyl-5- (γ-dimethylamino-n-butyl) -iminodibenzyl of m.p. 90;
3-dimethylsulfamoyl-5- [γ- (4'-methyl-piperazinyl) -ss-methyl-propyl] -iminodibenzyl, the oxalate of which melts at 193; 3-Dimethy @ sulfamoyl-5- (γ-methylamino-f-methyl-propyl) -iminodibenzyl, the oxalate of which melts at 216; 3-Dimethylsulfamoyl-5- [y- (1'-piperazinyl) -ss-methyl-propyl] -iminodibenzyl, the oxalate of which melts at 168.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH368962A CH407128A (en) | 1962-03-20 | 1962-03-20 | Process for the preparation of new iminodibenzyl derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH368962A CH407128A (en) | 1962-03-20 | 1962-03-20 | Process for the preparation of new iminodibenzyl derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH407128A true CH407128A (en) | 1966-02-15 |
Family
ID=4261396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH368962A CH407128A (en) | 1962-03-20 | 1962-03-20 | Process for the preparation of new iminodibenzyl derivatives |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH407128A (en) |
-
1962
- 1962-03-20 CH CH368962A patent/CH407128A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2461596A1 (en) | 8-HYDROXYCARBOSTYRIL DERIVATIVES, METHOD FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS | |
| CH625516A5 (en) | ||
| DE1620022A1 (en) | New 1-aminofluorenone derivatives and processes for their preparation | |
| DE1017612B (en) | Process for the preparation of tertiary amines, their acid addition salts and quaternary ammonium compounds | |
| DE2351281C3 (en) | Aminophenylethanolamine derivatives, their production and use | |
| DE2650961C2 (en) | ||
| DE2330124A1 (en) | ANILIDE DERIVATIVES, THEIR SALTS, PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
| CH407128A (en) | Process for the preparation of new iminodibenzyl derivatives | |
| AT233013B (en) | Process for the preparation of new iminodibenzyl derivatives | |
| DE2548668A1 (en) | NEW NAPHTHALINE COMPOUNDS, METHODS OF MANUFACTURING THEM AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
| DE2121996C3 (en) | Dibasic ethers of 2,6- and 2,7-dihydroxyanthraquinones of manufacture and pharmaceutical preparation | |
| CH659063A5 (en) | METHOD FOR PRODUCING BASIC OXIMAETHERS. | |
| AT233579B (en) | Process for the preparation of new iminodibenzyl derivatives | |
| AT217045B (en) | Process for the preparation of new monoalkylated or monohalogenated N-derivatives of 10,11-dihydro-5H-dibenzo [b, f] azepines and 5H-dibenzo [b, f] azepines | |
| DE2123992C3 (en) | 3,9-bis-ether of fluoranthene and its production | |
| AT222658B (en) | Process for the preparation of new derivatives of substituted 5H-dibenzo [b, f] azepines | |
| DE1185615B (en) | Process for the preparation of 1,4-disubstituted piperazines | |
| AT254194B (en) | Process for the preparation of new 5H-dihydrothiopyrano- [4,3-d] -pyrimidines | |
| DE2650966A1 (en) | IF NECESSARY, ETHERIZED BASIC METHYLOL COMPOUNDS AND THEIR SALTS | |
| DE2036181A1 (en) | Benzamidines and processes for their manufacture | |
| AT208869B (en) | Process for the production of new N-substituted azepines | |
| AT219611B (en) | Process for the preparation of new N-heterocyclic compounds and their salts | |
| AT230366B (en) | Process for the preparation of new 9-aminoalkyl-9,10-dihydro-9,10-ethano- (1 ', 2') -anthracenes and their salts or quaternary ammonium compounds | |
| AT214935B (en) | Process for the preparation of new N-derivatives of 10,11-dihydro-5-benzo [b, f] azepines and 5-dibenzo [b, f] -azepines | |
| DE2103119A1 (en) | N-substd-2,3-diphenyl-allylamines - prepn from the corresp alcohol via the bromide |